Robert A. Lenz

Insider Reports History

Location
Watertown, MA
Signature
/s/ Marc Panoff, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Robert A. Lenz:

Company Role Class Num Shares Value Price $ Report Date Ownership
Neumora Therapeutics, Inc. Head of R&D Common Stock 309,092 $516,616 $1.67 18 Feb 2025 Direct
Neumora Therapeutics, Inc. Head of R&D Stock Option (Right to Buy) 100,000 13 Feb 2025 Direct
LB PHARMACEUTICALS INC Director Stock Option (Right to Buy) 20,000 06 Mar 2026 Direct

Insider Reports Filed by Robert A. Lenz

Symbol Company Period Transactions Value $ Form Type Role Filing Time
LBRX LB PHARMACEUTICALS INC 06 Mar 2026 1 $0 4 Director 10 Mar 2026, 16:19
LBRX LB PHARMACEUTICALS INC 06 Mar 2026 0 $0 3 Director 10 Mar 2026, 16:16
NMRA Neumora Therapeutics, Inc. 18 Feb 2025 1 -$9,383 4 Head of R&D 20 Feb 2025, 17:12
NMRA Neumora Therapeutics, Inc. 13 Feb 2025 4 $0 4 Head of R&D 18 Feb 2025, 16:30
NMRA Neumora Therapeutics, Inc. 09 Oct 2024 2 -$208,110 4 Head of R&D 11 Oct 2024, 16:10
NMRA Neumora Therapeutics, Inc. 17 Sep 2024 2 -$492,827 4 Head of R&D 19 Sep 2024, 16:35
NMRA Neumora Therapeutics, Inc. 12 Sep 2024 1 -$376,665 4 Head of R&D 16 Sep 2024, 16:05
NMRA Neumora Therapeutics, Inc. 14 Feb 2024 2 $0 4 Head of R&D 16 Feb 2024, 16:13
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 2 $0 4 Head of R&D 18 Sep 2023, 17:58
NMRA Neumora Therapeutics, Inc. 14 Sep 2023 0 $0 3 Head of R&D 14 Sep 2023, 19:06